Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8471.72 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated sales of Rs 844.51 Crore, down 1.59 % from last quarter Sales of Rs 858.12 Crore and up 19.97 % from last year same quarter Sales of Rs 703.96 Crore Company reported net profit after tax of Rs 146.81 Crore in latest quarter.
Investment Rationale
The steady off-take of base molecules, coupled with increase in ANDA led business, is expected to improve overall return ratios for GRAN.
Promoter/FII Holdings
Promoters held 42 per cent stake in the company as of Dec 30, 2020, while FIIs held 26.4 per cent, DIIs 0.3 per cent and public and others 31.3 per cent.
